The impact of oral nicorandil pre-treatment on ST resolution and clinical outcome of patients with acute ST-segment elevation myocardial infarction undergoing primary coronary angioplasty: A randomized placebo controlled trial
The impact of oral nicorandil pre-treatment on ST resolution and clinical outcome of patients with acute ST-segment elevation myocardial infarction undergoing primary coronary angioplasty: A randomized placebo controlled trial
نویسندگان: بهناز اکبری , صمد غفاری باویل , ناصر اصلان آبادی , بهرام سهرابی ممقانی , لیلی پورافکاری , فریبرز اکبرزاده , حسن جوادزادگان , احمد سپرهم
کلمات کلیدی: Acute Myocardial Infarction
Oral Nicorandil
ST-Segment Resolution
Primary Angioplasty
Cardioprotection
نشریه: 42207 , 2 , 12 , 2020
| نویسنده ثبت کننده مقاله |
احمد سپرهم |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات قلب وعروق |
| کد مقاله |
72502 |
| عنوان فارسی مقاله |
The impact of oral nicorandil pre-treatment on ST resolution and clinical outcome of patients with acute ST-segment elevation myocardial infarction undergoing primary coronary angioplasty: A randomized placebo controlled trial |
| عنوان لاتین مقاله |
The impact of oral nicorandil pre-treatment on ST resolution and clinical outcome of patients with acute ST-segment elevation myocardial infarction undergoing primary coronary angioplasty: A randomized placebo controlled trial |
| ناشر |
9 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Abstract
Introduction: Literature has shown the effects of intravenous/intracoronary nicorandil on increased
myocardial salvage in patients with ST-segment elevation myocardial infarction (STEMI) treated with
mechanical reperfusion. However, the possible cardioprotective effect of oral nicorandil on the clinical
outcome prior to primary coronary angioplasty is not well documented. Our aim was to assess the
effect of oral nicorandil on primary percutaneous coronary intervention (PPCI).
Methods: A total of 240 patients with acute STEMI undergoing PPCI were randomly assigned to
oral nicorandil (Intervention, n=116) and placebo (Control, n=124) groups. The intervention group
received 20 mg oral nicorandil at the emergency department and another 20 mg oral nicorandil in
the catheterization laboratory just before the procedure. The control group received matched placebo.
Our primary outcome was ST-segment resolution ≥50% one hour after primary angioplasty. Secondary
outcome was in-hospital major adverse cardiovascular events (MACE), defined as a composite of
death, ventricular arrhythmia, heart failure and stroke.
Results: In the patients of intervention and control groups, the occurrence of ST-segment resolution ≥
50% were 68.1% and 62.9% respectively, (P = 0.27). In-hospital MACE occurred less frequently in the
intervention group, compared to placebo group (11.2% vs. 22.5%, P = 0.012).
Conclusion: Although the administration of oral nicorandil before primary coronary angioplasty did
not improve ST-segment resolution in patients with acute STEMI, its promoting effects was remarkable
on in-hospital clinical outcomes.
Clinical Registration: IRCT20140512017666N1 |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| The impact of oral nicorandil pre-treatment on ST resolution following PPCI.pdf | 1399/03/21 | 511482 | دانلود |